Learn more

DEBRECENI EGYETEM

Overview
  • Total Patents
    130
  • GoodIP Patent Rank
    31,969
  • Filing trend
    ⇧ 100.0%
About

DEBRECENI EGYETEM has a total of 130 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in Hungary, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are TEXAS HEART INST, UNIV DREXEL and AZAD PHARMACEUTICAL INGREDIENTS AG.

Patent filings in countries

World map showing DEBRECENI EGYETEMs patent filings in countries

Patent filings per year

Chart showing DEBRECENI EGYETEMs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tircsó Gyula 12
#2 Tóth Imre 12
#3 Kálmán Ferenc Krisztián 12
#4 Garda Zoltán 12
#5 Botár Richárd 10
#6 Fodor Tamás 10
#7 Bak Istvan 8
#8 Tosaki Arpad 8
#9 Nagy Viktória 8
#10 Juhasz Bela 7

Latest patents

Publication Filing date Title
WO2020025989A1 Treatment and diagnosis of breast cancer
HU1900023A1 Method for measuring the specific quality of botrytis cinerea in wines comprising botrytis cinerea preferably tokaji aszu
HU1900022A2 Method for measuring the oxidative effect of different wines with the exception of aszu wines
HU1900019A2 Light source for imaging diagnostics
WO2019069108A1 Prolonged-release, gastroretentive, moulded, solid dosage form and process for the preparation thereof
EP3638816A1 Methods for diagnosing breast cancer
HU1800091A2 Method and device for proceduring one or more predictors for the prognostic characterization of coronary artery sterosis
HU1800041A2 Process for the preparation of plant protein coagulum
HU1800012A2 Biopesticidal fungel strains and preparation thereof
HU1700455A2 Insert for cell migration assays and culture dish comprising said insert
HU1700430A2 Process for the environmentally friendly utilization of flue gas engine, by producing algae in high saline thermal water
HU1700238A2 Virus elimination from potato using chemotherapy
WO2017089849A1 New 6-oxa-3,9, 15-triaza-bicyclo[9.3.1 ]pentadec a- 1 ( 14), 1 1 ( 15), 12-triene derivatives based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
WO2017089848A1 New 2, 1 l -diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based mri contrast agents and 52mn based pet contrast agents
EP3380472A1 New 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca- 1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
HU1600582A2 2,11-diaza[3.3](2,6)-pyridinophane derivatives and their use as ligands in essential metal ion-based mri contrast agents
HU1600583A2 6-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives and their use as ligands in essential metal ion-based mri contrast agents
HU1600581A2 3,6,9,15-tetraaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives and their use as ligands in essential metal ion based mri contrast agents
WO2016120652A1 Muscle differentiation
WO2016120651A1 Runx3 dependent enhanced dendritic cell generation